Posted inLondon Stock Exchange
Scancell Holdings to merge with Nasdaq-listed Neuphoria Therapeutics in all-share deal
LONDON: UK-based clinical-stage biotech Scancell Holdings plc (AIM: SCLP) has agreed to acquire Nasdaq-listed Neuphoria Therapeutics Inc. (Nasdaq: NEUP) in an all-share merger, the companies announced today. Once the deal closes, the combined…











